Cover Image
市場調查報告書

印度的醫藥品、醫療產業(季度更新報告)

India Pharmaceuticals & Healthcare Report Q1 2018

出版商 BMI Research 商品編碼 191492
出版日期 內容資訊 英文 96 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的醫藥品、醫療產業(季度更新報告) India Pharmaceuticals & Healthcare Report Q1 2018
出版日期: 2017年10月31日 內容資訊: 英文 96 Pages
簡介

本報告提供印度的製藥、醫療產業結構和最新趨勢相關分析,產業今後10年的產業規模的動向的估計,課題(風險)和未來商機(利潤)相關評估,政府的政策、規定,宏觀經濟環境,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI的見解

SWOT分析

產業預測

  • 醫藥品市場預測
  • 醫療市場預測
  • 處方藥市場預測
  • 專利藥市場預測
  • 學名藥市場預測
  • 一般用(OTC)醫藥品市場預測
  • 醫藥品的對外貿易情形

產業的風險/利潤、等級

  • 亞太地區的製藥產業:多樣的機會與固有的風險
  • 產業的風險/利潤、等級

法規

  • 知識產權問題
  • 價格政策

市場概況

  • 醫療部門
  • 研究開發(R&D)
  • 臨床實驗
  • 流行病學

競爭環境

  • 研究為基礎的產業
  • 醫藥品的流通結構
  • 醫藥品的零售部門

企業簡介

  • Aurobindo Pharmaceutical
  • Cipla
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi India
  • Sun Pharmaceutical

人口結構的預測

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關注記
  • 風險/利潤、等級技術

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SSIN03_20180101

BMI View: India's evolving demographic and epidemiological profile will act as key drivers of growth within the country's pharmaceuticals and healthcare markets over the coming years. However, the impact of low levels of patent protection, price cuts, preference for generic medicines and low per capita pharmaceutical and healthcare spending will pose headwinds to innovative drugmaker opportunities in the country.

Table of Contents

BMI Industry View

  • Table: Headline Pharmaceuticals & Healthcare Forecasts (India 2015-2021)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (India 2013-2021)
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (India 2013-2021)
    • Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (India 2013-2021)
    • Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (India 2013-2021)
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Market Indicators, Historical Data And Forecasts (India 2013-2021)
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, Historical Data And Forecasts (India 2013-2021)
  • Generic Drug Market Forecast
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2013-2021)
  • OTC Medicine Market Forecast
    • Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (India 2013-2021)
  • Pharmaceutical Trade Forecast
    • Table: Pharmaceutical Trade Data And Forecasts (India 2015-2021)
    • Table: Pharmaceutical Trade Data And Forecasts local currency (India 2015-2021)

Industry Risk/Reward Index

  • Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
  • Industry Risk Reward Index

Regulatory Review

  • Intellectual Property Issues
    • Table: Special 301 Submission: Issues Raised For India
  • Pricing Regime

Market Overview

  • Healthcare Sector
    • Table: Healthcare Resources (India 2011-2016)
    • Table: Healthcare Personnel (India 2011-2016)
    • Table: Healthcare Activity (India 2011-2016)
  • Research & Development
  • Clinical Trials
  • Epidemiology
    • Table: Estimated Number Of New Cases Of Cancer In India

Competitive Landscape

  • Research-Based Industry
    • Table: Ordinary Members Of OPPI
    • Table: Multinational Market Activity
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector

Company Profile

  • Aurobindo Pharmaceutical
  • Cipla
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi India
  • Sun Pharmaceutical

Demographic Forecast

  • Table: Population Headline Indicators (India 1990-2025)
  • Table: Key Population Ratios (India 1990-2025)
  • Table: Urban/Rural Population & Life Expectancy (India 1990-2025)
  • Table: Population By Age Group (India 1990-2025)
  • Table: Population By Age Group % (India 1990-2025)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top